Charles River launches program for animal testing alternatives fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
The addition of ES cells and iPSCs will enhance Charles River’s portfolio of powerful research tools supporting acceleration of therapeutic development.
.
Baillie Gifford & Co. lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 79,572 shares of the medical research company’s stock after selling 5,524 shares during the period. […]
Charles River Laboratories International (NYSE:CRL) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares rose 7.3% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $237.16 and last traded at $236.41. Approximately 459,031 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of […]